Discovery of unique transcriptomic features of blood and tumor ILCs from CRC patients via single-cell immune landscape on ctILCsUncovering an ILC1-like subpopulation unique to the tumor tissue from CRC patientsIdentification of ILC2s SLAMF1 as an anti-tumor biomarker in CRC. This evidence concerns the gene SLAMF1 and colorectal carcinoma.